Clinical Utility of Rapid EGFR Genotyping in Advanced Lung Cancer

PURPOSE: Targeted therapy is the cornerstone of treatment of advanced EGFR-mutant non–small-cell lung cancer (NSCLC). Next-generation sequencing (NGS), the preferred method for genotyping, typically requires several weeks. Here, we assessed workflows designed to rapidly identify patients with action...

Descripción completa

Detalles Bibliográficos
Autores principales: Dagogo-Jack, Ibiayi, Azzolli, Christopher G., Fintelmann, Florian, Mino-Kenudson, Mari, Farago, Anna F., Gainor, Justin F., Jiang, Ginger, Piotrowska, Zofia, Heist, Rebecca S., Lennes, Inga T., Temel, Jennifer S., Mooradian, Meghan J., Lin, Jessica J., Digumarthy, Subba R., Batten, Julie M., Robinson, Hayley, Nose, Vania, Rivera, Miguel, Nardi, Valentina, Dias-Santagata, Dora, Le, Long P., Sequist, Lecia V., Pitman, Martha, Shepard, Jo-Anne O., Shaw, Alice T., Iafrate, A. John, Lennerz, Jochen K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200882/
https://www.ncbi.nlm.nih.gov/pubmed/30370396
http://dx.doi.org/10.1200/PO.17.00299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200882/
https://www.ncbi.nlm.nih.gov/pubmed/30370396
http://dx.doi.org/10.1200/PO.17.00299

Ejemplares similares